ICU
SeaStar Medical Holding Corporation
NASDAQ: ICU · HEALTHCARE · BIOTECHNOLOGY
$4.14
+6.98% today
Updated 2026-04-30
Market cap
$15.22M
P/E ratio
—
P/S ratio
12.33x
EPS (TTM)
$-5.86
Dividend yield
—
52W range
$2 – $13
Volume
0.2M
SeaStar Medical Holding Corporation (ICU) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $135000.00 | $1.23M |
| Revenue growth (YoY) | — | — | — | — | — | +814.1% |
| Cost of revenue | — | — | — | $0.00 | $0.00 | $53000.00 |
| Gross profit | — | — | — | $0.00 | $135000.00 | $1.18M |
| Gross margin | — | — | — | — | 100.0% | 95.7% |
| R&D | $4.03M | $2.77M | $2.82M | $5.97M | $9.11M | $7.52M |
| SG&A | $2.36M | $1.68M | $6.60M | $8.01M | $8.87M | $5.84M |
| Operating income | $-6.45M | $-4.45M | $-11.61M | $-14.21M | $-17.84M | $-12.18M |
| Operating margin | — | — | — | — | -13216.3% | -986.6% |
| EBITDA | $-5236.00 | $-4.38M | $-11.61M | $-11.14M | $-24.58M | $-12.18M |
| EBITDA margin | — | — | — | — | -18209.6% | -986.6% |
| EBIT | $-12.82M | $-8.81M | $-11.61M | $-25.15M | $-42.42M | — |
| Interest expense | $3.31M | $212000.00 | $630000.00 | $1.08M | $244000.00 | $329000.00 |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-3.28M | $-4.60M | $-23.01M | $-26.23M | $-24.83M | $-12.15M |
| Net income growth (YoY) | — | -40.3% | -400.7% | -14.0% | +5.3% | +51.1% |
| Profit margin | — | — | — | — | -18392.6% | -984.6% |